India, May 21 -- image credit- shutterstock

According to CareEdge Ratings, India's orthopaedic and cardiac implant sector, including exports, which stood at ~$2.4 to $2.7 billion in FY24, is expected to reach ~$4.5 to $5 billion by FY28, driven by strong domestic demand and gradually growing export presence.

Foreign MNCs, with their long track record of safety and efficacy, have built trust among medical practitioners, which has led to their dominance in the Indian market. However, Indian implant manufacturers are making rapid strides in the domestic market and are gradually expanding their presence in the export market.

CareEdge Ratings cited that with only 7.5% customs duty on the import of most coronary and orthopaedic implant produ...